Smith & Nephew (LON:SN) Share Price Passes Above 200 Day Moving Average - Time to Sell?

Key Points

• Smith & Nephew plc has seen its share price rise above the 200-day moving average, trading as high as GBX 1,334.50, with the last trade at GBX 1,319.
• Analysts have increased their target prices for Smith & Nephew, with Deutsche Bank setting a new target of GBX 1,400, while JPMorgan raised theirs to GBX 1,438, indicating a positive sentiment towards the stock.
• Insiders have been active in the market, purchasing over 4,800 shares of the company's stock worth nearly $13 million in the last 90 days, suggesting confidence in the company's future prospects.

Smith & Nephew plc (LON:SN - Get Free Report) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 1,155.27 ($15.48) and traded as high as GBX 1,334.50 ($17.88). Smith & Nephew shares last traded at GBX 1,319 ($17.68), with a volume of 4,952,053 shares trading hands.

Analyst Upgrades and Downgrades

SN has been the topic of several recent research reports. Deutsche Bank Aktiengesellschaft increased their target price on shares of Smith & Nephew from GBX 1,300 to GBX 1,400 and gave the stock a "hold" rating in a report on Wednesday, August 6th. Berenberg Bank lifted their price objective on shares of Smith & Nephew from GBX 1,100 to GBX 1,300 and gave the company a "hold" rating in a report on Thursday, August 7th. Finally, JPMorgan Chase & Co. upped their target price on Smith & Nephew from GBX 1,357 to GBX 1,438 and gave the stock an "overweight" rating in a report on Wednesday, August 6th. One equities research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of GBX 1,379.33.

Smith & Nephew Price Performance

The stock has a 50-day simple moving average of GBX 1,321.55 and a 200 day simple moving average of GBX 1,155.27. The company has a market cap of £14.50 billion, a PE ratio of 47.61, a P/E/G ratio of 0.46 and a beta of 0.62. The company has a quick ratio of 0.84, a current ratio of 2.51 and a debt-to-equity ratio of 70.22.

Insider Transactions at Smith & Nephew

In related news, insider Simon Lowth bought 355 shares of the firm's stock in a transaction on Friday, August 22nd. The shares were bought at an average price of GBX 1,384 per share, with a total value of £4,913.20. Also, insider Katarzyna Mazur Hofsaess bought 541 shares of the stock in a transaction on Friday, August 22nd. The shares were bought at an average cost of GBX 1,385 per share, with a total value of £7,492.85. Insiders bought 4,811 shares of company stock worth $12,947,701 in the last 90 days. Insiders own 0.19% of the company's stock.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.